Gene ID'd as potential therapeutic target for dementia in Parkinson's

by Washington University School of MedicineClumps of the Parkinson's protein alpha-synuclein (red) are visible inside neurons (green) in the brain of a mouse. Researchers at Washington Univer

Updated on: June 14,2024

Gene ID'd as potential therapeutic target for dementia in Parkinson's

by Washington University School of MedicineClumps of the Parkinson's protein alpha-synuclein (red) are visible inside neurons (green) in the brain of a mouse. Researchers at Washington Univer

Updated on:June 14,2024

AI reveals new insights into human brain activity

byFriedrich–Alexander University Erlangen–NurnbergTuning curve: a: LFP stream of 3 electrodes (shades of blue) during 50 ms pure tone stimuli (pure tone intensity: 110 dB SPL−70 dB SPL, frequenc

Updated on: September 23,2024

AI reveals new insights into human brain activity

byFriedrich–Alexander University Erlangen–NurnbergTuning curve: a: LFP stream of 3 electrodes (shades of blue) during 50 ms pure tone stimuli (pure tone intensity: 110 dB SPL−70 dB SPL, frequenc

Updated on:September 23,2024

Insurers balk at paying for Biogen's $56,000-a-year Alzheimer's treatment

by John Tozzi, Angelica Lavito and Anushree DaveCredit: CC0 Public DomainU.S. health insurers say they want more proof before paying for Biogen Inc.'s Aduhelm, stalling sales of the costly new Alz

Updated on: April 29,2024

Insurers balk at paying for Biogen's $56,000-a-year Alzheimer's treatment

by John Tozzi, Angelica Lavito and Anushree DaveCredit: CC0 Public DomainU.S. health insurers say they want more proof before paying for Biogen Inc.'s Aduhelm, stalling sales of the costly new Alz

Updated on:April 29,2024

Case study showcases effectiveness of multimodality approaches for diagnosing hydrocephalus

by Beijing Institute of Technology Press Co., LtdThis case demonstrates the efficacy of using multimodality approaches for iNPH diagnosis, which saves the patient time and clinical costs, worthy of fu

Updated on: September 05,2024

Case study showcases effectiveness of multimodality approaches for diagnosing hydrocephalus

by Beijing Institute of Technology Press Co., LtdThis case demonstrates the efficacy of using multimodality approaches for iNPH diagnosis, which saves the patient time and clinical costs, worthy of fu

Updated on:September 05,2024

More than just neurons: Scientists create new model for studying human brain inflammation

bySalk InstituteHuman astrocytes (green) extending processes that wrap around the host blood vessel (magenta). Credit: Salk InstituteThe brain is typically depicted as a complex web of neurons s

Updated on: March 13,2024

More than just neurons: Scientists create new model for studying human brain inflammation

bySalk InstituteHuman astrocytes (green) extending processes that wrap around the host blood vessel (magenta). Credit: Salk InstituteThe brain is typically depicted as a complex web of neurons s

Updated on:March 13,2024

Resveratrol appears to restore blood-brain barrier integrity in Alzheimer's disease

by Georgetown University Medical CenterSkeletal formula of trans-resveratrol. Image: WikipediaResveratrol, given to Alzheimer's patients, appears to restore the integrity of the blood-brain b

Updated on: March 09,2024

Resveratrol appears to restore blood-brain barrier integrity in Alzheimer's disease

by Georgetown University Medical CenterSkeletal formula of trans-resveratrol. Image: WikipediaResveratrol, given to Alzheimer's patients, appears to restore the integrity of the blood-brain b

Updated on:March 09,2024

Improved fitness can mean living longer without dementia

by Norwegian University of Science and TechnologyCredit: AI-generated imageStaying fit or improving fitness over time should be a goal for anyone who wants to reduce the likelihood of getting dem

Updated on: June 24,2024

Improved fitness can mean living longer without dementia

by Norwegian University of Science and TechnologyCredit: AI-generated imageStaying fit or improving fitness over time should be a goal for anyone who wants to reduce the likelihood of getting dem

Updated on:June 24,2024

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on: April 16,2024

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on:April 16,2024

Antibody therapy inspired by patient case reduces tau tangles in a preclinical model of Alzheimer's disease

by Mass General BrighamCredit: Pixabay/Pete Linforth.A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alz

Updated on: March 02,2024

Antibody therapy inspired by patient case reduces tau tangles in a preclinical model of Alzheimer's disease

by Mass General BrighamCredit: Pixabay/Pete Linforth.A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alz

Updated on:March 02,2024

Different biological variants discovered in Alzheimer's disease

by Amsterdam University Medical CenterCredit: Pixabay/CC0 Public DomainDutch scientists have discovered five biological variants of Alzheimer's disease, which may require different treatments. As

Updated on: February 24,2024

Different biological variants discovered in Alzheimer's disease

by Amsterdam University Medical CenterCredit: Pixabay/CC0 Public DomainDutch scientists have discovered five biological variants of Alzheimer's disease, which may require different treatments. As

Updated on:February 24,2024

Pilot study shows promise for remote cognitive rehabilitation for multiple sclerosis patients

by Kessler FoundationCredit: Anna Shvets from PexelsA pilot study shows promise for a new treatment option for individuals with memory impairments caused by multiple sclerosis (MS). Thearticle,

Updated on: July 08,2024

Pilot study shows promise for remote cognitive rehabilitation for multiple sclerosis patients

by Kessler FoundationCredit: Anna Shvets from PexelsA pilot study shows promise for a new treatment option for individuals with memory impairments caused by multiple sclerosis (MS). Thearticle,

Updated on:July 08,2024

Partially sighted may be at higher risk of dementia

by Anglia Ruskin UniversityCredit: CC0 Public DomainOlder people with vision loss are significantly more likely to suffer mild cognitive impairment, which can be a precursor to dementia, accordin

Updated on: May 05,2024

Partially sighted may be at higher risk of dementia

by Anglia Ruskin UniversityCredit: CC0 Public DomainOlder people with vision loss are significantly more likely to suffer mild cognitive impairment, which can be a precursor to dementia, accordin

Updated on:May 05,2024